Zobrazeno 1 - 3
of 3
pro vyhledávání: '"van der Vleuten MAJ"'
Publikováno v:
Arthritis & Rheumatism; Mar2005, Vol. 52 Issue 3, p770-778, 9p
Autor:
Groothuis PG, Jacobs DCH, Hermens IAT, Damming D, Berentsen K, Mattaar-Hepp E, Stokman MEM, Boekel TV, Rouwette M, van der Vleuten MAJ, Sesink A, Dijcks FA, Coumans RGE, Schouten J, Glaudemans DH, Wijk DV, Blomenröhr M, Kappers WA, Ubink R, van der Lee MMC, Dokter WHA
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Jun 01; Vol. 22 (6), pp. 765-777.
Autor:
Ubink R; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands. ruud.ubink@synthon.com., Dirksen EHC; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Rouwette M; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Bos ES; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Janssen I; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Egging DF; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Loosveld EM; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., van Achterberg TA; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Berentsen K; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., van der Lee MMC; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Bichat F; Oncodesign, Dijon, France., Raguin O; Oncodesign, Dijon, France., van der Vleuten MAJ; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Groothuis PG; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands., Dokter WHA; Department of Preclinical, Synthon Biopharmaceuticals BV, Nijmegen, the Netherlands.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2018 Nov; Vol. 17 (11), pp. 2389-2398. Date of Electronic Publication: 2018 Aug 09.